News
Hosted on MSN4mon
Carvedilol vs. Metoprolol: What’s the Difference? - MSNCarvedilol and metoprolol are both beta-blocker medications, which are a class of drugs used to treat various cardiovascular conditions like heart failure and hypertension (high blood pressure ...
Combining Carvedilol with certain foods, herbs, or alcohol & caffeine can trigger side-effects and alter the drug's efficacy.
He also suggests that if the safety of carvedilol is confirmed in larger studies, it would be appropriate to start therapy directly with carvedilol instead of propranolol.
Withdrawing digoxin from patients receiving carvedilol seems "generally deleterious"; findings demonstrate the continued value of digoxin for the treatment of persistent AF in the setting of HF.
Oncology/Hematology > Other Cancers Carvedilol No Help in Preventing Heart Failure in Childhood Cancer Survivors — While safe, the results do not support use of the drug in anthracycline-exposed ...
Beta-blocking agents reduce the risk of hospitalization and death in patients with mild-to-moderate heart failure, but little is known about their effects in severe heart failure. We evaluated 2289 ...
Carvedilol has the capacity to block both the β-1 and β-2 adrenergic receptors, as well as the α-1 receptors. There is evidence to indicate that full adrenergic blockade by carvedilol improves ...
BOSTON -- Carvedilol (Coreg, Coreg CR) helped to mitigate cardiac risk in patients undergoing pheochromocytoma surgery, researchers reported here. In a comparison of several blood pressure (BP ...
We conducted a retrospective analysis of the influence of race on the response to carvedilol among patients with heart failure who were enrolled in the U.S. Carvedilol Heart Failure Trials Program ...
Two preparations of carvedilol given to patients with heart failure were found nearly bioequivalent. Researchers for the Study to Compare the Effects of Coreg CR and Coreg IR on HF in Subjects ...
For this study, researchers sought to investigate the impact of carvedilol vs metoprolol initiation on 1-year mortality among patients receiving hemodialysis.
The widely prescribed beta blocker carvedilol has strong antiarrhythmic effects on the heart, but the underlying mechanisms have been unclear. Qiang Zhou et al. now show that carvedilol, unlike ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results